| Dr Amanda Ashton-sager, MD | |
|
Renown Medical Center, Sierra Pathology Associates, 1155 Mill Street, Reno, NV 89509 | |
| (775) 982-4545 | |
| Not Available |
| Full Name | Dr Amanda Ashton-sager |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 23 Years |
| Location | Renown Medical Center, Sierra Pathology Associates, Reno, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023069788 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Antioch | Antioch, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types. A series of experiments that demonstrate the successful use of fat cells as part of a feeder layer to support prolonged growth of hHSCs in culture is reported in an article in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.
Meanwhile, Kansas applies for waiver to shift Medicaid beneficiaries into managed care plans and Medicaid costs in Kentucky weigh on one insurer.
The Government of Quebec's Ministère de la santé et des services sociaux has approved the addition of Revlimid(R) (lenalidomide) to the Province's Drug Formulary as a third-line therapy for multiple myeloma patients. The cost of the drug will be reimbursed under the Province's medicare system.
For people infected with the human papilloma virus (HPV), the likelihood of clearing the infection and avoiding HPV-related cancer may depend less on the body's disease-fighting arsenal than has been generally assumed.
› Verified 1 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types. A series of experiments that demonstrate the successful use of fat cells as part of a feeder layer to support prolonged growth of hHSCs in culture is reported in an article in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.
Meanwhile, Kansas applies for waiver to shift Medicaid beneficiaries into managed care plans and Medicaid costs in Kentucky weigh on one insurer.
The Government of Quebec's Ministère de la santé et des services sociaux has approved the addition of Revlimid(R) (lenalidomide) to the Province's Drug Formulary as a third-line therapy for multiple myeloma patients. The cost of the drug will be reimbursed under the Province's medicare system.
For people infected with the human papilloma virus (HPV), the likelihood of clearing the infection and avoiding HPV-related cancer may depend less on the body's disease-fighting arsenal than has been generally assumed.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Ashton-sager, MD Po Box 3947, Reno, NV 89505-3947 Ph: (775) 334-3450 | Dr Amanda Ashton-sager, MD Renown Medical Center, Sierra Pathology Associates, 1155 Mill Street, Reno, NV 89509 Ph: (775) 982-4545 |
News Archive
One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types. A series of experiments that demonstrate the successful use of fat cells as part of a feeder layer to support prolonged growth of hHSCs in culture is reported in an article in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers.
NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.
Meanwhile, Kansas applies for waiver to shift Medicaid beneficiaries into managed care plans and Medicaid costs in Kentucky weigh on one insurer.
The Government of Quebec's Ministère de la santé et des services sociaux has approved the addition of Revlimid(R) (lenalidomide) to the Province's Drug Formulary as a third-line therapy for multiple myeloma patients. The cost of the drug will be reimbursed under the Province's medicare system.
For people infected with the human papilloma virus (HPV), the likelihood of clearing the infection and avoiding HPV-related cancer may depend less on the body's disease-fighting arsenal than has been generally assumed.
› Verified 1 days ago
Michael Scott Powell, MD Pathology Medicare: Medicare Enrolled Practice Location: 343 Elm St, Suite 206, Reno, NV 89503 Phone: 775-746-3400 Fax: 775-746-3411 | |
Dr. Christie Elliott, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1155 Mill St, Reno, NV 89502 Phone: 775-982-4545 Fax: 775-982-4546 | |
Dr. Edwin Steven Sweeney, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1350 Stardust St, Ste D, Reno, NV 89503 Phone: 775-746-3400 Fax: 775-746-3411 | |
Dr. Anton Rets, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 475 Kirman Ave, Reno, NV 89502 Phone: 775-982-7880 | |
Paul David Freeman, PATHOLOGIST ASSISTAN Pathology Medicare: Not Enrolled in Medicare Practice Location: 1155 Mill St, Reno, NV 89502 Phone: 775-334-3450 | |
Dr. Donald James Lawrie Jr., M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1350 Stardust St, Ste D, Reno, NV 89503 Phone: 775-746-3400 Fax: 775-746-3411 |